Literature DB >> 25378595

CD4 T cells specific for a latency-associated γ-herpesvirus epitope are polyfunctional and cytotoxic.

Michael L Freeman1, Claire E Burkum1, Tres Cookenham1, Alan D Roberts1, Kathleen G Lanzer1, Gail E Huston1, Meghan K Jensen1, John Sidney2, Bjoern Peters2, Jacob E Kohlmeier1, David L Woodland1, Linda F van Dyk3, Alessandro Sette2, Marcia A Blackman4.   

Abstract

The oncogenic γ-herpesviruses EBV and Kaposi sarcoma-associated herpesvirus are ubiquitous human pathogens that establish lifelong latent infections maintained by intermittent viral reactivation and reinfection. Effector CD4 T cells are critical for control of viral latency and in immune therapies for virus-associated tumors. In this study, we exploited γHV68 infection of mice to enhance our understanding of the CD4 T cell response during γ-herpesvirus infection. Using a consensus prediction approach, we identified 16 new CD4 epitope-specific responses that arise during lytic infection. An additional epitope encoded by the M2 protein induced uniquely latency-associated CD4 T cells, which were not detected at the peak of lytic infection but only during latency and were not induced postinfection with a latency-deficient virus. M2-specific CD4 T cells were selectively cytotoxic, produced multiple antiviral cytokines, and sustained IL-2 production. Identification of latency-associated cytolytic CD4 T cells will aid in dissecting mechanisms of CD4 immune control of γ-herpesvirus latency and the development of therapeutic approaches to control viral reactivation and pathology.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25378595      PMCID: PMC4301266          DOI: 10.4049/jimmunol.1302060

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Analysis of virus-specific CD4(+) t cells during long-term gammaherpesvirus infection.

Authors:  E Flaño; D L Woodland; M A Blackman; P C Doherty
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Gammaherpesvirus lytic gene expression as characterized by DNA array.

Authors:  Joo Wook Ahn; Kenneth L Powell; Paul Kellam; Dagmar G Alber
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Cutting edge: activation of virus-specific CD4 T cells throughout γ-herpesvirus latency.

Authors:  Michael L Freeman; Claire E Burkum; Kathleen G Lanzer; Meghan K Jensen; Mushtaq Ahmed; Eric J Yager; Emilio Flaño; Gary M Winslow; David L Woodland; Marcia A Blackman
Journal:  J Immunol       Date:  2011-11-11       Impact factor: 5.422

4.  CD4 and CD8 T cells directly recognize murine gammaherpesvirus 68-immortalized cells and prevent tumor outgrowth.

Authors:  Xiaozhan Liang; Rebecca L Crepeau; Weijun Zhang; Samuel H Speck; Edward J Usherwood
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

5.  Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation.

Authors:  Meagan A Jacoby; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice.

Authors:  B Ebrahimi; B M Dutia; D G Brownstein; A A Nash
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

7.  Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.

Authors:  Heather M Long; Alison M Leese; Odette L Chagoury; Shawn R Connerty; Jared Quarcoopome; Laura L Quinn; Claire Shannon-Lowe; Alan B Rickinson
Journal:  J Immunol       Date:  2011-05-27       Impact factor: 5.422

8.  Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse.

Authors:  Gary M Winslow; Alan D Roberts; Marcia A Blackman; David L Woodland
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

9.  Memory inflation: continuous accumulation of antiviral CD8+ T cells over time.

Authors:  Urs Karrer; Sophie Sierro; Markus Wagner; Annette Oxenius; Hartmut Hengel; Ulrich H Koszinowski; Rodney E Phillips; Paul Klenerman
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

10.  MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.

Authors:  Heather M Long; Odette L Chagoury; Alison M Leese; Gordon B Ryan; Eddie James; Laura T Morton; Rachel J M Abbott; Shereen Sabbah; William Kwok; Alan B Rickinson
Journal:  J Exp Med       Date:  2013-04-08       Impact factor: 14.307

View more
  9 in total

Review 1.  Coinfections: Another Variable in the Herpesvirus Latency-Reactivation Dynamic.

Authors:  Tiffany A Reese
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

2.  NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection.

Authors:  Nikki B Marshall; Allen M Vong; Priyadharshini Devarajan; Matthew D Brauner; Yi Kuang; Ribhu Nayar; Elizabeth A Schutten; Catherine H Castonguay; Leslie J Berg; Stephen L Nutt; Susan L Swain
Journal:  J Immunol       Date:  2016-12-28       Impact factor: 5.422

Review 3.  Adaptive immune responses to Kaposi's sarcoma-associated herpesvirus.

Authors:  Angela Nalwoga; Denise Whitby
Journal:  Curr Opin Immunol       Date:  2022-07-08       Impact factor: 7.268

4.  TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors.

Authors:  Timothy T Spear; Glenda G Callender; Jeffrey J Roszkowski; Kelly M Moxley; Patricia E Simms; Kendra C Foley; David C Murray; Gina M Scurti; Mingli Li; Justin T Thomas; Alexander Langerman; Elizabeth Garrett-Mayer; Yi Zhang; Michael I Nishimura
Journal:  Cancer Immunol Immunother       Date:  2016-02-03       Impact factor: 6.968

Review 5.  Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.

Authors:  Elena Muraro; Anna Merlo; Debora Martorelli; Michela Cangemi; Silvia Dalla Santa; Riccardo Dolcetti; Antonio Rosato
Journal:  Front Immunol       Date:  2017-02-27       Impact factor: 7.561

6.  ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection.

Authors:  Baila Samreen; Sha Tao; Karsten Tischer; Heiko Adler; Ingo Drexler
Journal:  Front Immunol       Date:  2019-12-18       Impact factor: 7.561

7.  Deletion of immune evasion genes provides an effective vaccine design for tumor-associated herpesviruses.

Authors:  Gurpreet Brar; Nisar A Farhat; Alisa Sukhina; Alex K Lam; Yong Hoon Kim; Tiffany Hsu; Leming Tong; Wai Wai Lin; Carl F Ware; Marcia A Blackman; Ren Sun; Ting-Ting Wu
Journal:  NPJ Vaccines       Date:  2020-11-05       Impact factor: 7.344

8.  Conquering the Host: Determinants of Pathogenesis Learned from Murine Gammaherpesvirus 68.

Authors:  Yiping Wang; Scott A Tibbetts; Laurie T Krug
Journal:  Annu Rev Virol       Date:  2021-09-29       Impact factor: 14.263

9.  From Superantigens to "Real" Viral Antigens.

Authors:  Marcia A Blackman
Journal:  Viral Immunol       Date:  2020-04       Impact factor: 2.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.